Sensipar
Product Images NDC 54868-5616

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sensipar (NDC 54868-5616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (0377f8b9 Cb10 47e5 Aedd 18d1ec662943 01)

Image 1 (0377f8b9 Cb10 47e5 Aedd 18d1ec662943 01)
Chemical structure diagram of the active ingredient in Sensipar (Physicians Total Care, Inc.). The structure includes a trifluoromethyl-substituted aromatic ring and a hydrochloride salt form, consistent with cinacalcet hydrochloride.*
FDA Label Image

Figure 1. (0377f8b9 Cb10 47e5 Aedd 18d1ec662943 02)

Figure 1. (0377f8b9 Cb10 47e5 Aedd 18d1ec662943 02)
A line graph comparing iPTH levels (pg/mL) over 26 weeks between Sensipar and placebo groups. The x-axis represents weeks, and the y-axis shows iPTH levels. Sensipar group is marked in red with a downward trend, while placebo group in black shows relatively stable iPTH levels.*
FDA Label Image

Figure 2. (0377f8b9 Cb10 47e5 Aedd 18d1ec662943 03)

Figure 2. (0377f8b9 Cb10 47e5 Aedd 18d1ec662943 03)
A line graph comparing Calcium x Phosphorus (Ca x P) levels in mg/dL over 26 weeks between Sensipar (red line with diamonds) and placebo (black dashed line with circles). The x-axis represents weeks, and the y-axis represents Ca x P levels. Sensipar shows a notable decrease in Ca x P levels over time compared to the placebo group.*
FDA Label Image

Figure 3. (0377f8b9 Cb10 47e5 Aedd 18d1ec662943 04)

Figure 3. (0377f8b9 Cb10 47e5 Aedd 18d1ec662943 04)
Line graph depicting calcium levels (mg/dL) over several weeks in patients with parathyroid carcinoma. The x-axis represents weeks with phases labeled as Titration and Maintenance, while the y-axis shows calcium concentration ranging from 8 to 16 mg/dL. Data points with error bars indicate calcium measurements at specified time points.*
FDA Label Image

Figure 4. (0377f8b9 Cb10 47e5 Aedd 18d1ec662943 05)

Figure 4. (0377f8b9 Cb10 47e5 Aedd 18d1ec662943 05)
A line graph depicting calcium levels (mg/dL) over an 80-week period with titration and maintenance phases. The x-axis represents weeks, and the y-axis shows calcium concentration. Data points include error bars, indicating variation at each time point, in a study related to intractable pHPT.*
FDA Label Image

Image Of Package Label (5616)

Image Of Package Label (5616)
Label of Sensipar 30 mg tablets, distributed by Physicians Total Care, Inc. The label shows a package of 30 tablets with lot number 0000 and an expiration date of January 2060. The NDC is 54868-5616-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.